← Eichor
Condition: Cannabis Induced Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cannabis Induced Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
Phase 2 · 1 location(s) · BC Centre on Substance Use · NCT05985850Reducing Breathlessness With Dronabinol in COPD Patients
Phase 3 · 1 location(s) · Vejle Hospital · NCT06473701Environment and Lung Cancer
NA · 3 location(s) · Centre Chirurgical Marie Lannelongue · NCT05119244ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Phase 2 · 22 location(s) · University of Birmingham · NCT05629702RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05704582A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
Phase 2 · 1 location(s) · University Medical Center Groningen · NCT06518434Age-dependent Effects of Smoked and Oral Delta-9-THC
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05865470Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLE
NA · 1 location(s) · King's College London · NCT07656350Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults
NA · 1 location(s) · University of Pittsburgh · NCT06743373Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
NA · 2 location(s) · Nova Scotia Health Authority · NCT07056894Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms
Phase 2 · 1 location(s) · Laboratorio Elea Phoenix S.A. · NCT06629389Cannabis-Tobacco Co-Use Treatment Study
Phase 3 · 1 location(s) · Medical University of South Carolina · NCT06883162Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults
Phase 2 · 1 location(s) · Southwest Autism Research & Resource Center · NCT06526208Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia
Phase 2 · 1 location(s) · Rambam Health Care Campus · NCT06946940Cannabis Use and Outcomes in Black and White Patients With Cancer
Phase N/A · 3 location(s) · State University of New York at Buffalo · NCT06037681Cannabis and Processing Emotions Study
NA · 1 location(s) · Auburn University · NCT06907979Role of Pavlovian Mechanisms for Control Over Substance Use
Phase N/A · 1 location(s) · Technische Universität Dresden · NCT06701487Cohort Study on Medical Students' Mental Health
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT07305701Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT05859347Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
NA · 8 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT04871048Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement
Phase 3 · 1 location(s) · Hadassah Medical Organization · NCT04816994Real World Evidence on the Use of Medical Cannabis in Pediatrics
Phase N/A · 1 location(s) · University of Manitoba · NCT05863910A Mobile App to Reduce and/or Quit Cannabis Use
NA · 2 location(s) · Alba González-Roz, PhD · NCT06733792Alcohol Use Disorder and Cannabidiol
Phase 2/Phase 3 · 1 location(s) · University of Colorado, Denver · NCT05613608Integrated Treatment for Enhancing Growth in Recovery During Adolescence
NA · 2 location(s) · Massachusetts General Hospital · NCT06395467High Potency Cannabis: Acute and Protracted Effects
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT06859723Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
NA · 1 location(s) · University of Basel · NCT06975020CANnabinoids in Pediatric ONCology
Phase 1/Phase 2 · 3 location(s) · University of Manitoba · NCT05754840Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Phase N/A · 1 location(s) · University Hospital Pilsen · NCT07160153Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06293040
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.